Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visionace is a comprehensive multivitamin and mineral supplement specifically formulated to support long-term eye health and maintain normal vision. Developed by Vitabiotics and marketed in certain regions by Bolar Pharmaceuticals, it contains a blend of antioxidants, vitamins, and minerals, including lutein, zeaxanthin, zinc, vitamin A, and riboflavin. The formulation is designed to protect ocular tissues from oxidative stress and provide essential nutrients that support the retina and lens. It is typically used as a dietary supplement for individuals looking to maintain ocular health or those at risk of age-related eye conditions such as macular degeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Visionace.